Research programme: gp41 inhibitor - Kemia
Latest Information Update: 26 Feb 2008
At a glance
- Originator Kemia
- Class Small molecules
- Mechanism of Action HIV fusion inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 13 May 2005 Preclinical trials in HIV infections treatment in USA (unspecified route)